Cargando…
Engineered multivalent self-assembled binder protein against SARS-CoV-2 RBD
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic since December 2019, and with it, a push for innovations in rapid testing and neutralizing antibody treatments in an effort to solve the spread and fatality of the disease. One such solution to both of these pr...
Autores principales: | Britton, Dustin, Punia, Kamia, Mahmoudinobar, Farbod, Tada, Takuya, Jiang, Xunqing, Renfrew, P. Douglas, Bonneau, Richard, Landau, Nathaniel R., Kong, Xiang-Peng, Montclare, Jin Kim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396458/ https://www.ncbi.nlm.nih.gov/pubmed/36034180 http://dx.doi.org/10.1016/j.bej.2022.108596 |
Ejemplares similares
-
Protein-Engineered Fibers For Drug Encapsulation Traceable
via (19)F Magnetic Resonance
por: Britton, Dustin, et al.
Publicado: (2023) -
Self-assembled peptide amphiphiles function as multivalent binder with increased hemagglutinin affinity
por: Hüttl, Christine, et al.
Publicado: (2013) -
Supramolecular polymerization of sulfated dendritic peptide amphiphiles into multivalent L-selectin binders
por: Straßburger, David, et al.
Publicado: (2021) -
Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab́ fragments
por: Casey, J L, et al.
Publicado: (1999) -
Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein
por: Lu, Qizhong, et al.
Publicado: (2021)